1. 37 Pathway to a controlled human infection model for Leishmania major. (September 2022) Authors: Parkash, Vivak; Ashwin, Helen; Jones, Georgina; Sadlova, Jovana; Vojtkova, Barbora; Jaffe, Charles; Volf, Petr; Layton, Alison; Kaye, Paul; Lacey, Charles Journal: Clinical infection in practice Issue: Volume 15(2022)supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Leishmaniasis: new approaches to disease control. Issue 7385 (15th February 2003) Authors: Davies, Clive R; Kaye, Paul; Croft, Simon L; Sundar, Shyam Journal: BMJ Issue: Volume 326:Issue 7385(2003) Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC 8489 Clinical development of a therapeutic vaccine for prevention of post kala azar dermal leishmaniasis. (24th April 2019) Authors: Kaye, Paul; Musa, Ahmed; Olobo, Joseph; Mbuchi, Margaret; Mekuria, Asrat Hailu; D'Alessio, Flavia; Houard, Sophie; Leroy, Odile Journal: BMJ global health Issue: Volume 4(2019)Supplement 3 Page Start: A9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report. (July 2020) Authors: Balasingam, Shobana; Bejon, Philippe; Berthels, Nele; Bull, Susan; Catchpole, Andrew; Chi, Primus; Chilengi, Roma; Cox, Rebecca; Davies, Hugh; Durbin, Anna; Emary, Kate; Emerson, Claudia; Frenck, Robert; Grimwade, Olivia; Hobbs, Marcia; Kang, Gagandeep; Kaye, Paul; Le Doare, Kirsty; Levine, Mike;... Journal: Biologicals Issue: Volume 66(2020) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗